Ensysce Biosciences Inc.

NAS: ENSC

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Dec 1, 2021, 11:31 a.m.

/zigman2/quotes/202092269/composite

$

1.57

Change

-0.01 -0.63%

Volume

Volume 41,126

Quotes are delayed by 20 min

/zigman2/quotes/202092269/composite

Previous close

$ 1.58

$ 1.57

Change

-0.01 -0.63%

Day low

Day high

$1.50

$1.61

Open

52 week low

52 week high

$1.37

$23.99

Open

Annual Financials for Ensysce Biosciences Inc.

Fiscal year is January-December. All values USD millions. 2017201820192020 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -----
Depreciation -----
Amortization of Intangibles -----
Gross Income -----
2017201820192020 5-year trend
SG&A Expense -146,6951.56M3.33M1.37M
Research & Development -----
Other SG&A -146,6951.56M3.33M1.37M
Other Operating Expense --(600,000)--
Unusual Expense --(8,397)-(5.42M)
EBIT after Unusual Expense --(950,843)-4.06M
Non Operating Income/Expense -119,140---
Non-Operating Interest Income --3.63M4.25M719,646
Equity in Affiliates (Pretax) -----
Interest Expense ----220,000
Gross Interest Expense ----220,000
Interest Capitalized -----
Pretax Income -(27,558)2.68M921,1544.56M
Income Tax -3,635553,916555,200244,493
Income Tax - Current Domestic -3,635544,119556,964244,493
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic --9,797(1,764)-
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(31,193)2.12M365,9544.31M
Minority Interest Expense -----
Net Income -(31,193)2.12M365,9544.31M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(31,193)2.12M365,9544.31M
Preferred Dividends -----
Net Income Available to Common -(31,193)2.12M365,9544.31M
EPS (Basic) -()0.090.020.41
Basic Shares Outstanding -25.2M24.96M23.58M10.59M
EPS (Diluted) -()0.090.020.41
Diluted Shares Outstanding -25.2M24.96M23.58M10.59M
EBITDA -(146,700)-(3.33M)(1.37M)
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.